NDC 50090-1745-01 - Losartan Potassium and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-1745
- Requested NDC
- 50090-1745-01
- Package NDCs from labels
- 50090-1745-0, 50090-1745-1, 50090-1745-2, 50090-1745-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-02-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium and Hydrochlorothiazide - A-S Medication Solutions | A-S Medication Solutions | 2026-02-14 | Human Prescription Drug Label |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-1745-0 | Losartan Potassium and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 41 | |
| 50090-1745-1 | Losartan Potassium and Hydrochlorothiazide | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 41 | |
| 50090-1745-2 | Losartan Potassium and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 41 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-1745 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 38 | Current NDC, Legacy NDC, 3 package rows | 20241105_dc9512cf-db66-40e9-afcb-1d6a722772e8.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-1745-0 | EA - Each | 50090-1745 | a7af2e3c-f12a-430b-9077-f9e506ff28f6 | 1 | 2018-10-11 |
| 50090-1745-1 | EA - Each | 50090-1745 | e3817854-fa12-449e-b7de-c240aad086f3 | 1 | 2018-10-11 |
| 50090-1745-2 | EA - Each | 50090-1745 | 7a366fca-d58e-4deb-a70e-471ca46697f5 | 1 | 2024-12-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aveeno Baby Daily Moisture Face Mineral Sunscreen SPF30 | TITANIUM DIOXIDE, ZINC OXIDE | Kenvue Brands LLC | 5b3109da-3019-73c4-e063-6394a90abb08 | 2026-09-11 | Warnings | 15FIX9V2JP |
| MISSHA M Perfect Cover BB No.31 | OCTINOXATE, ZINC OXIDE, TITANIUM DIOXIDE | Able C&C Co., Ltd. | 4a254907-9ef9-e6c3-e063-6394a90a1741 | 2026-09-11 | Warnings | 15FIX9V2JP |
| MISSHA M Perfect Cover BB No.33 | OCTINOXATE, ZINC OXIDE, TITANIUM DIOXIDE | Able C&C Co., Ltd. | 4a25692d-df90-322f-e063-6294a90a4622 | 2026-09-11 | Warnings | 15FIX9V2JP |
| MISSHA M Perfect Cover BB No.45 | OCTINOXATE, ZINC OXIDE, TITANIUM DIOXIDE | Able C&C Co., Ltd. | 4a25912c-5b28-50f7-e063-6294a90a897d | 2026-09-11 | Warnings | 15FIX9V2JP |
| Spironolactone and hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Advagen Pharma Ltd. | 9c6c8815-50d8-4a3c-b348-98d5084c1408 | 2026-09-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | St. Mary's Medical Park Pharmacy | 8a1de4e2-3aca-a4d3-e053-2995a90a1a41 | 2026-09-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 71691ccf-0ed9-4a14-8da6-7ab9b9698f52 | 2026-09-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Par Health USA, LLC | 268d12e8-1cfc-4086-b613-8fd94f2d7c4e | 2026-09-11 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| MISSHA M PERFECT COVER BB.13 | OCTINOXATE, ZINC OXIDE, TITANIUM DIOXIDE | Able C&C Co., Ltd. | 48f73555-79ce-ae27-e063-6394a90ad41f | 2026-09-10 | Warnings | 15FIX9V2JP |
| MISSHA M Perfect Cover BB No.21 | OCTINOXATE, ZINC OXIDE, TITANIUM DIOXIDE | Able C&C Co., Ltd. | 49fb0a82-b3ef-9784-e063-6294a90a0676 | 2026-09-10 | Warnings | 15FIX9V2JP |
| Stay Ageless Tinted Mineral Sunscreen | BROAD SPECTRUM SPF30 | W Aesthetics | 5b0f2c8f-d6fa-5e25-e063-6394a90a084d | 2026-09-09 | Warnings | 15FIX9V2JP |
| Kids Mineral Sunscreen SPF 50 | ZINC OXIDE | Hello Bello | 5b19f2ae-c7e5-c44c-e063-6394a90a0e68 | 2026-09-09 | Warnings | 15FIX9V2JP |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | GLENMARK PHARMACEUTICALS INC., USA | ab73a6d8-2e33-4fdc-a896-6c68ab772da6 | 2026-09-08 | Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 5ee165a3-39a4-4d12-aff2-a6fb3309ce39 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | AvKARE | 1b303136-dccd-178b-e063-6394a90a35f8 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Psoriasis Control | CENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDE | Forces of Nature | 2db33771-0bb9-49f8-84fa-dddc28e4ba26 | 2026-09-04 | Warnings | ETJ7Z6XBU4 |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 7dc3414b-dcb5-4b11-bca7-c0fa3f474aea | 2026-09-03 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Losartan potassium | LOSARTAN POTASSIUM | REMEDYREPACK INC. | a397502e-abe7-49cf-97c7-d53a616947eb | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| BMNP Silicea | SILICEA | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a58454f-aed6-24ba-e063-6294a90a47fb | 2026-08-31 | Warnings | ETJ7Z6XBU4 |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Edenbridge Pharmaceuticals LLC. | 295532b5-65c8-40c3-8d27-cfd334d12802 | 2026-08-28 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.